Open AccessHeterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Author(s) -
Chloé Dimeglio,
Fabrice Hérin,
Isabelle Da-Silva,
Isabelle Jougla,
Claire Pradere,
Marion Porcheron,
Guillaume MartinBlondel,
Sabine ChapuyRegaud,
Jacques Izopet
Publication year - 2021
Publication title -
clinical infectious diseases
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab705
Subject(s) - medicine , covid-19 , virology , vaccination , coronavirus , neutralizing antibody , heterologous , antibody response , betacoronavirus , antibody , severe acute respiratory syndrome coronavirus , immunology , virus , infectious disease (medical specialty) , biology , outbreak , disease , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom